Transcranial magnetic stimulation (TMS) is an FDA-approved treatment for major depressive disorder, and has shown positive effects for PTSD. It is a safe and noninvasive treatment that uses magnetic fields to induce a small electric current in the brain. It is in this study, we use a more concise and more precise way to deliver TMS, and investigate the mechanisms of TMS for PTSD.
This study is a registered clinical trial, and is supported by the National Institute of Mental Health (K01MH121653, PI van Rooij, 2020-2025), the Brain and Behavior Research Foundation (BBRF), and Foundation for Neurofeedback and Neuromodulation Research (FNNR).